Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
AMSBIO unveils rapid immunofluorescent staining kit for 3D cell cultures
, /in Product News /by panglobalAccelerating organoid and spheroid research
Revvity’s EUROIMMUN introduces APOE genotyping assay for Alzheimer’s treatment risk assessment
, /in Product News /by panglobalNew diagnostic tool aids in personalised anti-amyloid therapy decisions
Integra Biosciences introduces new serological pipet controller with repeat dispense function
, /in Product News /by panglobalAdvanced features aim to enhance precision and consistency in laboratory pipetting Integra Biosciences has unveiled its latest serological pipet controller, the PIPETBOY GENIUS. This new instrument introduces a repeat dispense function, designed to improve consistency and precision in laboratory pipetting tasks.
Asimov unveils comprehensive AAV gene therapy development platform
, /in Product News /by panglobalNew system aims to streamline design and production processes Asimov, a synthetic biology company based in Boston, Massachusetts, has announced the launch of its AAV Edge System, a suite of tools designed to enhance the development of adeno-associated viral (AAV) gene therapies. The system offers an integrated approach to address challenges in safety, efficacy, manufacturability, […]
Takara Bio Europe introduces high-throughput single-cell NGS system
, /in Product News /by panglobalNew technology aims to enhance biomarker discovery in oncology research
Greiner Bio-One’s serological pipettes earn ACT ecolabel for sustainability
, /in E-News /by panglobalIn a move towards greater environmental responsibility in the life sciences sector, Greiner Bio-One has announced that its serological pipettes have been awarded the ACT (Accountability, Consistency and Transparency) ecolabel. This certification, granted by the non-profit organisation My Green Lab, represents a significant step in providing scientists and procurement specialists with verified information about the […]
Synexa Life Sciences acquires Alderley Analytical, expanding bioanalytical capabilities
, /in E-News /by panglobalTThe acquisition of Alderley Analytical by Synexa Life Sciences marks a significant development in the bioanalytical services sector. This strategic move, announced on 7 October 2024, aims to broaden Synexa’s capabilities in biomarker and bioanalytical assays, particularly in the areas of mass spectrometry and ligand binding assays.
Cancer Research UK funds development of world’s first ovarian cancer prevention vaccine
, /in E-News /by panglobalCancer Research UK has announced funding of up to £600,000 for a groundbreaking project aimed at developing the world’s first ovarian cancer prevention vaccine. The initiative, led by Professor Ahmed Ahmed at the University of Oxford, seeks to leverage recent advancements in immunology and cancer biology to create a vaccine that could potentially prevent ovarian […]
Nuclera announces key leadership appointments to drive protein expression innovation
, /in E-News /by panglobalIn a move that signals a shift towards commercial growth and technological advancement, Cambridge-based biotechnology company Nuclera has announced significant changes to its leadership structure. The firm, known for its eProtein Discovery system – a benchtop platform designed to accelerate protein expression and purification workflows – has promoted three key executives to senior roles.
AzurBio Pharma launches with aim to help biopharma companies navigate European regulatory landscape
, /in E-News /by panglobalParis-based AzurBio Pharma has officially launched, positioning itself as a strategic partner for biopharmaceutical companies seeking to bring innovative treatments to the European market. The company, founded by industry veteran Corinne Schmitz, aims to streamline the often complex process of European market entry, with a particular focus on rare and serious diseases with unmet medical […]